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Abstract
The implementation of the presumptive donor law in Brazil is expected to increase
the availability of organs for transplantation. As medical management of end-stage
organ dysfunction continues to improve, increasing numbers of potential transplant
recipients will be available to meet this supply. There is mounting evidence that
supports the involvement of skilled psychiatric practitioners in the selection of
transplant candidates. Data supporting the influence of psychosocial factors on
compliance and therefore medical outcomes continues to grow. The literature review
allows delineating the components and rationale for comprehensive psychosocial
evaluations as a component of preoperative transplantation evaluation.
Resumo
A implementação da figura do doador presumido e as recentes mudanças na
regulamentação do transplante no Brasil irão aumentar a disponibilidade de órgãos
no País. O avanço no cuidado de doentes portadores de insuficiência grave de
órgãos, por sua vez, irá aumentar a demanda por esses mesmos órgãos. Há
considerável literatura apoiando o envolvimento de psiquiatras no processo de
seleção dos candidatos ao transplante. Pesquisas mostram que fatores psicossociais
influenciam na adesão ao tratamento e, conseqüentemente, no prognóstico desses
pacientes. A partir de uma revisão da literatura existente, articula-se os componentes
e lógicas de uma avaliação psicossocial abrangente, propondo sua inserção na
avaliação pré-operatória dos pacientes para o recebimento de órgão.
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INTRODUCTION
Brazil’s reintegration of psychiatric and medical
services in the general hospital has been reviewed in
recent years.7 Programs such as solid organ transplan-
tation, where costly scarce resources are provided to
a limited number of recipients represent a particular
area where psychiatric involvement could be exceed-
ingly valuable.
The recent implementation of the presumptive do-
nor law is expected to increase the availability of or-
gans for transplantation in Brazil. The number of pa-
tients in need of transplantation will likely also grow
along with the problems inherent in individuals with
chronic medical conditions. The proposal is that trans-
plant programs develop interdisciplinary teams to par-
ticipate in the selection of patients who will be compli-
ant with life sustaining treatment after transplantation.
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The importance of psychosocial involvement in
candidate selection is generally recognized in trans-
plantation programs in the United States and else-
where.34 Earlier surveys27,34 documented that 100%
of responding liver transplant programs and high per-
centages of other organ transplant programs use psy-
chosocial assessments as a component of candidate
selection criteria.
Ongoing psychiatric involvement in transplant pro-
grams is supported by the high rates of psychiatric co-
morbidity seen in individuals with end-stage organ
dysfunction. Rates of depression range from a point
prevalence of 20%18 to 45%38 in heart disease patients.
Craven9 examined a consecutive series of applicants
for lung transplantation and found that 50% reported a
history of psychiatric disorder. Trzepacz et al49 found
that 20% of liver transplant candidates had concomi-
tant adjustment disorders and 4.5% had major depres-
sion; 9% met the criteria for alcohol abuse or alcohol
dependence, and 2% met criteria for abuse of other
substances. Of patients undergoing dialysis, major de-
pression has been described in as few as 5%42 and as
many as 22%.31 Rundell’s37 work demonstrated that
individuals seen in a transplant setting differ from those
seen in general hospitals and are more likely to have
psychiatric issues.
A growing body of literature links significant neu-
ropsychiatric side effects to cyclosporine, tacrolimus,
and other elements of the transplant regimen.1,3,4,6,10-
13,16,17,21,24-26,30,35,43,47-48,51-54
 These effects are often more
pronounced in individuals who have demonstrated
preoperative difficulties.
Potential roles for a mental health team lead by psy-
chiatry in a transplantation program are listed in Table
1. The present article is meant to highlight the psy-
chiatric aspects in the assessment of candidates for
transplantation, and articulate a framework for the
performance of such an evaluation. Many of these
areas are supported by Freeman et al20 who previously
delineated the potential roles for a psychiatrist on a
transplantation team.
individual’s risk factors for having difficulty in the
post-operative period while recognizing their
strengths. A detailed psychiatric assessment (Table
2) is generally completed after the initial medical
screening and prior to the completion of all necessary
physiologic testing for the transplantation. There is
increasing evidence that psychosocial factors are as-
sociated with post-transplantation noncompliance and
morbidity. Substance abuse history, personality dis-
order, and global psychosocial risks were associated
with compliance problems.14,19,39-40 There is also evi-
dence documenting that the number of rejection epi-
sodes after cardiac transplantation were linked to glo-
bal psychosocial risks.8 Experienced psychiatric prac-
titioners are able to identify individuals who are at an
increased risk of having compliance difficulties over
time, and alert the team about the steps to be taken to
minimize this risk.
Table 1 – Potential roles for a psychiatrist in a transplant team.
1. Candidate selection
2. Counseling
3. Treatment of personality and other psychiatric disorders
4. Peri-operative assessment and treatment
5. Family adjustment
6. Staff issues around morbidity and mortality
Table 2 – Psychosocial evaluation of patients for transplant
(House,23 1993).
•Patient profile: relationship, educational, work and legal
history
•Organ failure: cause, complications, course, compliance
with treatment
•Means of coping with illness, past and present
•Expectations of surgery, including fantasies
•Support: family, friends, church and employment
•Existing psychiatric difficulties and treatment plan
•Past psychiatric history
•Family psychiatric history
•Substance abuse history
•Mental status exam: consider neuropsychological tests
•Understanding of procedure and competence to sign
informed consent
Psychiatric assessment
The role of a comprehensive psychosocial evalua-
tion in transplantation selection is to define an
Assessment of compliance should include attention
to patterns of adherence to appointments, medications,
and medical advice, especially regarding the individu-
al’s ability to cease harmful habits such as nicotine and
alcohol use. Additionally, the ability to incorporate di-
etary and exercise advice should be included here.
Adopting a new diet or exercise habits are extremely
difficult and speaks to the patient’s motivation to adapt
themselves to the rigors of transplantation.
In the pre-transplant period, one should also address
the individual’s understanding of the importance of
strict adherence to a treatment plan as a way to maxi-
mize their survival in the post transplant period by
keeping their “new” organ safe. Detailed review of
the neuropsychiatric and general physical external
effects of immunosuppressive medications should be
mentioned to allow support and further explanation,
if requested. The ability of a candidate to acknowl-
edge and appreciate the potential for a negative im-
pact of transplantation translates into their ability to
incorporate the full spectrum of possibilities in the
post transplant period.
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The ability to acknowledge potential positive and
negative aspects of transplantation is an essential com-
ponent of competence. The need to assess competence
arises in all procedures that involve risks, and trans-
plant surgery is not an exception. To be competent to
accept the procedure the patient needs to understand
the medical need for such a procedure, the risks in-
volved, the alternatives, and the risks involved in re-
jecting the procedure. Overall, medically ill patients
do not show an increased risk of being unable of giv-
ing consent to the treatment.2 However, the severity
of the conditions requiring transplantation make the
likelihood of disorders with consciousness impairment
greater and therefore make the assessment of compe-
tence crucial. Table 3 lists factors, which potentially
make an individual unable to render competent judge-
ments. When subtle questions concerning cognitive
status arise the clinician should obtain neuropsycho-
logical testing if the patient is stable enough to com-
plete them.23
liver disease patients candidates for liver transplanta-
tion have alcohol abuse as an etiology.29 The Beresford
Algorithm5 emphasizes the importance of a careful
diagnosis, recognition of alcoholism as a disease by
the patient and their family, assessment of social stabil-
ity factors, and evaluation for the attainment of com-
monly accepted predictors of long-term abstinence
from alcohol. For alcohol abusers receiving liver trans-
plantation, positive identification with non-drinking
persons, good social support system, effective time
structuring, and a smooth medical course are corre-
lated with abstinence.32
Social support is another factor associated with the
transplantation outcome. In Brazil this assessment
should involve not only family availability, but also
organizations for self-support, and churches. A pri-
mary care provider should be assigned. His/her roles,
including driving the patient to the hospital and doc-
tors’ appointments, assisting with medications and
supervising the patient’s overall well being, need to
be explicitly discussed. The program of “health
agents” – agentes de saúde – and family doctors, avail-
able in some areas of the country, should also be con-
tacted to gather information regarding compliance
with medical care and to have cooperation for assis-
tance in the post operative period.
Motivation to undergo transplantation is an issue
that the psychiatrist should assess to understand the
candidate’s reasons for pursuing this treatment. Un-
realistic expectations and ambivalence may be a sign
for potential problems in the post transplant period. It
should always be determined if the individual is un-
dergoing transplantation evaluation due to their own
benefit, or if family members, employers, or other
third parties with their own interests are coercing them.
The potential transplant candidate’s coping strate-
gies are generally reviewed. For some individuals who
have developed significant physical limitations as a
result of their end-stage illness, developing whole new
patterns of behavior may cause significant stress and
frustration. Self-destructive responses to stress such
as alcohol consumption or denial should be addressed.
Patterns of coping with stress and dealing with medi-
cal issues will generally continue unless interventions
to change them are made.
In an attempt to encourage standardization and re-
search, two rating scales have been developed that
incorporate the variables described above in assess-
ing psychosocial factors in transplant patients: the
Psychosocial Assessment for Candidates for Trans-
plant (PACT)33 and the Transplantation Evaluation
Rating Scale (TERS).50 Each has been shown to be
Table 3 – Medical conditions which may significantly impair
the ability of an individual to consent to transplantation.
•Severe hepatic encephalopathy
•Cardiogenic shock
•Recent sudden death/Cardiac arrest
•Hepato-renal syndrome
•Uremia
•Toxicity form necessary treatment (e.g. Lidocaine,
Nitroprusside)
Psychiatric co-morbidity is another area that should
be addressed in a complete assessment. There is no
clear decision algorithm on how to weight the impact
of mental illness in candidates for transplantation. The
assessment of these patients is important and they
should be given a comprehensive treatment plan aimed
at modifying remediable problems. The individual’s
willingness and ability to attend to these issues and
their ultimate ability to be compliant with treatment
protocols should be the ultimate deciding factors in
candidate listing decisions.
The literature shows mixed results in transplanting
individuals with severe and persistent mental illnesses
such as schizophrenia.15,41 Owen Surman46 is a propo-
nent of improving access to transplantation and has
proposed that kidney transplantation is a better alter-
native than chronic dialysis for psychiatrically ill pa-
tients. Most literature on transplanting individuals
with serious psychiatric illness is based on anecdotal
reports.15,41
Substance abuse is important because of its strong
correlation with non-compliance and graft loss.22
Currently in the United States one third of end-stage
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inter-rater reliable and have a good predictive value
in determining individuals at risk for poor outcome
and noncompliance.36
Psychosocial contraindications
The primary psychosocial reasons to reject a
transplantation candidate are based on their inabil-
ity to comply with medications and the rehabilita-
tion treatment because of the increased risk of graft
loss.23 The significant risks and the exceedingly
high costs of transplantation are such that psycho-
social factors which negatively affect outcome need
to be recognized. Where these exist and will likely
prevent graft survival, programs should refuse list-
ing these patients until the issues are addressed.
Utilization of a behavioral treatment contract may
allow the team sufficient time to discern if the pa-
tient may ultimately be able to cooperate and be
successfully transplanted. Table 4 provides a list
of absolute and relative contraindications for trans-
plantation developed by Strouse & Skotzko.44
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